%0 Journal Article
%T Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination
%A Akansha Chowdhary
%A Dian Wang
%A Kirtesh R. Patel
%A Lydia Usha
%A Melody A. Cobleigh
%A Neilayan Sen
%A Parul N. Barry
%A Ruta D. Rao
%J Archive of "Advances in Radiation Oncology".
%D 2019
%R 10.1016/j.adro.2019.03.011
%X Palbociclib is a selective cyclin-dependent kinase 4/6 inhibitor approved for metastatic ER+/HER2- breast cancer. Preclinical evidence suggests a possible synergistic effect of palbociclib when combined with radiation therapy (RT); however, the toxicity of this pairing is unknown. We report preliminary results on the use of this combination
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639750/